BioCentury
ARTICLE | Company News

MannKind Corp, Sanofi sales and marketing update

February 23, 2015 8:00 AM UTC

Sanofi launched Afrezza in the U.S. to treat adults with Type I and II diabetes. The wholesale acquisition cost (WAC) is $226.06 for two inhalers. Sanofi has exclusive, worldwide rights to develop an...